Week 5: Module 3 – Anxiety Disorders and Obsessive-Compulsive and Related Disorders
Please refer to the class list tab to see which group you belong in. It is simply a numerical standing based alphabetically. Count your standing from the top down. Class members 1-7 are in Group 1, 8-14 are in Group 2, and 14-20 and beyond are Group 3. This is not a group project. You each post an individual response to the initial topic.
Group 1:
Please describe GABA, its role in anxiety, and benzodiazepines. What words of caution are prudent when discussing benzodiazepines?
Group 2:
Please discuss the role of serotonin in anxiety. Also, why are SSRIs first-line treatments in anxiety?
Group 3:
Pharmacological treatment strategies for anxiety disorders and OCD seem very similar but there are certain caveats, like differences in evidence or specific FDA indications, for example, that can help to guide your treatment decisions. Discuss the differences in pharmacological treatment you have noted for these four disorders. Citing references like up-to-date treatment guidelines and primary literature may help your research.
PLACE THIS ORDER OR A SIMILAR ORDER WITH ONLINE NURSING PAPERS TODAY AND GET AN AMAZING DISCOUNT